Literature DB >> 1755987

Cytokines and cancer: experimental systems.

T Blankenstein1, D A Rowley, H Schreiber.   

Abstract

The transfer of certain cytokine genes into cancer cells can provide very powerful suppression of tumor growth in the absence of any toxic side effects. Some of these cytokines, such as interleukin-4, granulocyte colony-stimulating factor and tumor necrosis factor, can mediate powerful immune suppression even in T-cell-deficient animals and appear to be effective for poorly or non-antigenic tumors. However, approaches must be found to induce or deliver cytokines locally at the tumor site.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1755987     DOI: 10.1016/0952-7915(91)90098-l

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  9 in total

1.  Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation.

Authors:  Kavitha Viswanathan; Firdaus S Dhabhar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-07       Impact factor: 11.205

Review 2.  Antigen-presenting cell engineering. The molecular toolbox.

Authors:  M L Tykocinski; D R Kaplan; M E Medof
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

3.  Tumor Therapy Applying Membrane-bound Form of Cytokines.

Authors:  Young Sang Kim
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

4.  Inhibitory effect of locally produced and exogenous interleukin-6 on tumor growth in vivo.

Authors:  G J Dougherty; J D Thacker; R S Lavey; A Belldegrun; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

5.  Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2.

Authors:  F Arienti; F Belli; L Rivoltini; C Gambacorti-Passerini; L Furlan; L Mascheroni; A Prada; M Rizzi; E Marchesi; M Vaglini
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

6.  Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts.

Authors:  P Siesjö; E Visse; M Lindvall; L Salford; H O Sjögren
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

7.  Eriobotrya japonica hydrophilic extract modulates cytokines in normal tissues, in the tumor of Meth-A-fibrosarcoma bearing mice, and enhances their survival time.

Authors:  Heba A Alshaker; Nidal A Qinna; Fadi Qadan; Mona Bustami; Khalid Z Matalka
Journal:  BMC Complement Altern Med       Date:  2011-02-04       Impact factor: 3.659

8.  Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.

Authors:  L M Zheng; D M Ojcius; F Garaud; C Roth; E Maxwell; Z Li; H Rong; J Chen; X Y Wang; J J Catino; I King
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

9.  Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma.

Authors:  A Stoppacciaro; C Melani; M Parenza; A Mastracchio; C Bassi; C Baroni; G Parmiani; M P Colombo
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.